NVR S A (Gleevec 100 mg)
Generic Name: imatinib
Pill imprint NVR S A has been identified as Gleevec 100 mg.
Gleevec is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; chronic eosinophilic leukemia; systemic mastocytosis; acute lymphoblastic leukemia (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Gleevec 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- NVR S A
- 100 mg
- 9.00 mm
- Prescription only
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide red
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54868-5289||Physicians Total Care Inc (repackager)|
|68258-9028||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about Gleevec (imatinib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.